Imunon Investor Relations Material
Latest events
Q4 2023
Imunon
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Imunon Inc
Access all reports
Imunon Inc., formerly Celsion Corporation, a clinical stage biotechnology company, focuses on the development of novel theragnostic technologies for cancer, including the use of radiolabeled DNA plasmids to treat cancer. Celsion has developed, among other, ThermoDox, a DNA plasmid with its proprietary heat-activated liposomal delivery technology, which is designed to improve the effectiveness of cancer immunotherapies such as vaccines and adoptive cell therapies. The company's customers are pharmaceutical and biotechnology companies, research institutions, hospitals and clinics.
Latest articles
Four Decades of IPOs: An Overview
An overview of the stock and IPO market from the 80's until today, highlighting important events and trends.
24 Apr 2024
Larry Page: The Mastermind Behind Google
Explore the journey of Larry Page from a tech-savvy youth to co-founding Google and leading Alphabet.
24 Apr 2024
Mark Leonard: The Mysterious Brain Behind Constellation Software
Information about Mark Leonard is scarce, and one of the only ways to “get to know” him is through his shareholder letters. Join us in an attempt to do so.
24 Apr 2024
Ticker symbol
Country
🇺🇸 United States